bigbio/spl_adr_200db
收藏资源简介:
--- language: - en bigbio_language: - English license: cc0-1.0 multilinguality: monolingual bigbio_license_shortname: CC0_1p0 pretty_name: SPL ADR homepage: https://bionlp.nlm.nih.gov/tac2017adversereactions/ bigbio_pubmed: False bigbio_public: True bigbio_tasks: - NAMED_ENTITY_RECOGNITION - NAMED_ENTITY_DISAMBIGUATION - RELATION_EXTRACTION --- # Dataset Card for SPL ADR ## Dataset Description - **Homepage:** https://bionlp.nlm.nih.gov/tac2017adversereactions/ - **Pubmed:** False - **Public:** True - **Tasks:** NER,NED,RE The United States Food and Drug Administration (FDA) partnered with the National Library of Medicine to create a pilot dataset containing standardised information about known adverse reactions for 200 FDA-approved drugs. The Structured Product Labels (SPLs), the documents FDA uses to exchange information about drugs and other products, were manually annotated for adverse reactions at the mention level to facilitate development and evaluation of text mining tools for extraction of ADRs from all SPLs. The ADRs were then normalised to the Unified Medical Language System (UMLS) and to the Medical Dictionary for Regulatory Activities (MedDRA). ## Citation Information ``` @article{demner2018dataset, author = {Demner-Fushman, Dina and Shooshan, Sonya and Rodriguez, Laritza and Aronson, Alan and Lang, Francois and Rogers, Willie and Roberts, Kirk and Tonning, Joseph}, title = {A dataset of 200 structured product labels annotated for adverse drug reactions}, journal = {Scientific Data}, volume = {5}, year = {2018}, month = {01}, pages = {180001}, url = { https://www.researchgate.net/publication/322810855_A_dataset_of_200_structured_product_labels_annotated_for_adverse_drug_reactions }, doi = {10.1038/sdata.2018.1} } ```
language: - 英语 bigbio_language: - 英语 license: CC0 1.0 multilinguality: 单语(monolingual) bigbio_license_shortname: CC0_1p0 pretty_name: SPL ADR homepage: https://bionlp.nlm.nih.gov/tac2017adversereactions/ bigbio_pubmed: 否 bigbio_public: 是 bigbio_tasks: - 命名实体识别(NAMED_ENTITY_RECOGNITION) - 命名实体消歧(NAMED_ENTITY_DISAMBIGUATION) - 关系抽取(RELATION_EXTRACTION) --- # SPL ADR数据集卡片 ## 数据集说明 - **主页:** https://bionlp.nlm.nih.gov/tac2017adversereactions/ - **关联PubMed:** 否 - **公开性:** 是 - **任务:** 命名实体识别(NER)、命名实体消歧(NED)、关系抽取(RE) 美国食品药品监督管理局(United States Food and Drug Administration,FDA)与美国国家医学图书馆(National Library of Medicine)合作构建了一款试点数据集,该数据集收录了200种经FDA批准的药物的已知不良反应标准化信息。结构化产品标签(Structured Product Labels,SPLs)是FDA用于交换药品及其他产品相关信息的官方文档,本数据集针对提及级别的不良反应对其开展了人工标注,以助力开发和评估用于从所有SPLs中提取药物不良反应(Adverse Drug Reactions,ADRs)的文本挖掘工具。后续,所标注的ADRs被归一化至统一医学语言系统(Unified Medical Language System,UMLS)以及监管活动医学词典(Medical Dictionary for Regulatory Activities,MedDRA)。 ## 引用信息 @article{demner2018dataset, author = {Demner-Fushman, Dina and Shooshan, Sonya and Rodriguez, Laritza and Aronson, Alan and Lang, Francois and Rogers, Willie and Roberts, Kirk and Tonning, Joseph}, title = {A dataset of 200 structured product labels annotated for adverse drug reactions}, journal = {Scientific Data}, volume = {5}, year = {2018}, month = {01}, pages = {180001}, url = { https://www.researchgate.net/publication/322810855_A_dataset_of_200_structured_product_labels_annotated_for_adverse_drug_reactions }, doi = {10.1038/sdata.2018.1} }
数据集概述:SPL ADR
基本信息
- 语言: 英语
- 许可证: CC0-1.0
- 多语言性: 单语种
- 任务:
- 命名实体识别 (NER)
- 命名实体消歧 (NED)
- 关系抽取 (RE)
数据集描述
- 主页: https://bionlp.nlm.nih.gov/tac2017adversereactions/
- 是否公开: 是
- 是否包含PubMed数据: 否
该数据集由美国食品药品监督管理局(FDA)与国家医学图书馆合作创建,包含200种FDA批准药物的已知不良反应的标准化信息。数据集中的结构化产品标签(SPL)文档经过手动标注,以促进从所有SPL中提取ADR的文本挖掘工具的开发和评估。ADR随后被规范化为统一医学语言系统(UMLS)和医疗词典监管活动(MedDRA)。
引用信息
@article{demner2018dataset, author = {Demner-Fushman, Dina and Shooshan, Sonya and Rodriguez, Laritza and Aronson, Alan and Lang, Francois and Rogers, Willie and Roberts, Kirk and Tonning, Joseph}, title = {A dataset of 200 structured product labels annotated for adverse drug reactions}, journal = {Scientific Data}, volume = {5}, year = {2018}, month = {01}, pages = {180001}, url = { https://www.researchgate.net/publication/322810855_A_dataset_of_200_structured_product_labels_annotated_for_adverse_drug_reactions }, doi = {10.1038/sdata.2018.1} }




